BIOVENTUS INC - A (BVS) Stock Fundamental Analysis
NASDAQ:BVS - Nasdaq - US09075A1088 - Common Stock - Currency: USD
Taking everything into account, BVS scores 4 out of 10 in our fundamental rating. BVS was compared to 503 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of BVS while its profitability can be described as average. BVS scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
BVS had positive earnings in the past year.
BVS had a positive operating cash flow in the past year.
In multiple years BVS reported negative net income over the last 5 years.
BVS had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -4.57%, BVS is in the better half of the industry, outperforming 66.84% of the companies in the same industry.
BVS has a Return On Equity of -21.34%. This is in the better half of the industry: BVS outperforms 60.43% of its industry peers.
BVS has a Return On Invested Capital of 3.71%. This is in the better half of the industry: BVS outperforms 73.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.57% | ||
| ROE | -21.34% | ||
| ROIC | 3.71% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BVS has a Operating Margin of 4.27%. This is in the better half of the industry: BVS outperforms 69.52% of its industry peers.
BVS's Operating Margin has declined in the last couple of years.
BVS has a Gross Margin of 67.45%. This is in the better half of the industry: BVS outperforms 74.33% of its industry peers.
In the last couple of years the Gross Margin of BVS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.27% | ||
| PM (TTM) | N/A | ||
| GM | 67.45% |
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BVS is destroying value.
Compared to 1 year ago, BVS has more shares outstanding
BVS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BVS has been reduced compared to a year ago.
2.2 Solvency
BVS has an Altman-Z score of 0.94. This is a bad value and indicates that BVS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.94, BVS perfoms like the industry average, outperforming 48.13% of the companies in the same industry.
The Debt to FCF ratio of BVS is 14.89, which is on the high side as it means it would take BVS, 14.89 years of fcf income to pay off all of its debts.
BVS has a Debt to FCF ratio of 14.89. This is in the better half of the industry: BVS outperforms 73.26% of its industry peers.
A Debt/Equity ratio of 2.15 is on the high side and indicates that BVS has dependencies on debt financing.
BVS has a Debt to Equity ratio of 2.15. This is amonst the worse of the industry: BVS underperforms 86.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.15 | ||
| Debt/FCF | 14.89 | ||
| Altman-Z | 0.94 |
ROIC/WACC0.38
WACC9.82%
2.3 Liquidity
BVS has a Current Ratio of 1.43. This is a normal value and indicates that BVS is financially healthy and should not expect problems in meeting its short term obligations.
BVS has a Current ratio of 1.43. This is in the lower half of the industry: BVS underperforms 77.54% of its industry peers.
A Quick Ratio of 0.89 indicates that BVS may have some problems paying its short term obligations.
The Quick ratio of BVS (0.89) is worse than 81.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 0.89 |
3. Growth
3.1 Past
BVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.45%, which is quite impressive.
Measured over the past years, BVS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.93% on average per year.
The Revenue has grown by 8.59% in the past year. This is quite good.
Measured over the past years, BVS shows a quite strong growth in Revenue. The Revenue has been growing by 11.01% on average per year.
EPS 1Y (TTM)45.45%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%14.29%
Revenue 1Y (TTM)8.59%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-4.31%
3.2 Future
The Earnings Per Share is expected to grow by 19.79% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.48% on average over the next years.
EPS Next Y41.11%
EPS Next 2Y38.04%
EPS Next 3Y19.79%
EPS Next 5YN/A
Revenue Next Year0.05%
Revenue Next 2Y3.03%
Revenue Next 3Y3.48%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 13.23, BVS is valued correctly.
Based on the Price/Earnings ratio, BVS is valued cheaply inside the industry as 87.17% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.32. BVS is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 7.09, the valuation of BVS can be described as very cheap.
Based on the Price/Forward Earnings ratio, BVS is valued cheaply inside the industry as 96.26% of the companies are valued more expensively.
BVS is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.23 | ||
| Fwd PE | 7.09 |
4.2 Price Multiples
87.17% of the companies in the same industry are more expensive than BVS, based on the Enterprise Value to EBITDA ratio.
85.56% of the companies in the same industry are more expensive than BVS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.8 | ||
| EV/EBITDA | 11.85 |
4.3 Compensation for Growth
BVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BVS's earnings are expected to grow with 19.79% in the coming years.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y38.04%
EPS Next 3Y19.79%
5. Dividend
5.1 Amount
BVS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.35
-0.25 (-3.79%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners71.8%
Inst Owner Change5.35%
Ins Owners2.55%
Ins Owner Change5.47%
Market Cap521.59M
Analysts77.14
Price Target15.3 (140.94%)
Short Float %2%
Short Ratio2.85
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)158.87%
Min EPS beat(2)78.22%
Max EPS beat(2)239.51%
EPS beat(4)4
Avg EPS beat(4)149.48%
Min EPS beat(4)78.22%
Max EPS beat(4)239.51%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.37%
Min Revenue beat(2)-0.04%
Max Revenue beat(2)4.79%
Revenue beat(4)3
Avg Revenue beat(4)4.21%
Min Revenue beat(4)-0.04%
Max Revenue beat(4)8.81%
Revenue beat(8)7
Avg Revenue beat(8)4.85%
Revenue beat(12)9
Avg Revenue beat(12)2.01%
Revenue beat(16)11
Avg Revenue beat(16)2.19%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)1.61%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)19.39%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.25%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.91%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.23 | ||
| Fwd PE | 7.09 | ||
| P/S | 0.92 | ||
| P/FCF | 21.8 | ||
| P/OCF | 20.48 | ||
| P/B | 3.52 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.85 |
EPS(TTM)0.48
EY7.56%
EPS(NY)0.9
Fwd EY14.1%
FCF(TTM)0.29
FCFY4.59%
OCF(TTM)0.31
OCFY4.88%
SpS6.91
BVpS1.8
TBVpS-3.11
PEG (NY)0.32
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.57% | ||
| ROE | -21.34% | ||
| ROCE | 4.69% | ||
| ROIC | 3.71% | ||
| ROICexc | 3.88% | ||
| ROICexgc | 21.12% | ||
| OM | 4.27% | ||
| PM (TTM) | N/A | ||
| GM | 67.45% | ||
| FCFM | 4.21% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y44.62%
ROICexcg growth 5Y-8.7%
ROICexc growth 3Y36.86%
ROICexc growth 5Y-12.41%
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
F-Score4
Asset Turnover0.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.15 | ||
| Debt/FCF | 14.89 | ||
| Debt/EBITDA | 4.3 | ||
| Cap/Depr | 3.1% | ||
| Cap/Sales | 0.27% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 34.48% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z | 0.94 |
F-Score4
WACC9.82%
ROIC/WACC0.38
Cap/Depr(3y)9.96%
Cap/Depr(5y)13.06%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.45%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%14.29%
EPS Next Y41.11%
EPS Next 2Y38.04%
EPS Next 3Y19.79%
EPS Next 5YN/A
Revenue 1Y (TTM)8.59%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-4.31%
Revenue Next Year0.05%
Revenue Next 2Y3.03%
Revenue Next 3Y3.48%
Revenue Next 5YN/A
EBIT growth 1Y22.32%
EBIT growth 3Y6.82%
EBIT growth 5Y-5.11%
EBIT Next Year20.58%
EBIT Next 3Y13.24%
EBIT Next 5YN/A
FCF growth 1Y3671.34%
FCF growth 3Y34.24%
FCF growth 5Y-0.3%
OCF growth 1Y155.46%
OCF growth 3Y19.05%
OCF growth 5Y-0.96%